Deals & business · first seen yesterday, updated yesterday

Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCare

1 outlet Eli Lilly

Eli Lilly has committed $100 million in upfront and near-term payments to InnoCare Pharma to form a five-target drug discovery pact. The deal features up to $3.25 billion in milestones.

Summary from Fierce Biotech - Biotech.

Coverage 1 article · 1 outlet

Fierce Biotech - Biotech yesterday
Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCare